Correlation Between Bioatla and Syndax Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Bioatla and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bioatla and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bioatla and Syndax Pharmaceuticals, you can compare the effects of market volatilities on Bioatla and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bioatla with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bioatla and Syndax Pharmaceuticals.

Diversification Opportunities for Bioatla and Syndax Pharmaceuticals

0.78

Correlation Coefficient

Bioatla  Syndax Pharmaceuticals

Poor diversification

The 3 months correlation between Bioatla and Syndax is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Bioatla and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and Bioatla is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bioatla are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of Bioatla i.e., Bioatla and Syndax Pharmaceuticals go up and down completely randomly.

Pair Corralation between Bioatla and Syndax Pharmaceuticals

Given the investment horizon of 90 days Bioatla is expected to generate 1.41 times more return on investment than Syndax Pharmaceuticals. However, Bioatla is 1.41 times more volatile than Syndax Pharmaceuticals. It trades about -0.05 of its potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about -0.09 per unit of risk. If you would invest  174.00  in Bioatla on September 19, 2024 and sell it today you would lose (43.00) from holding Bioatla or give up 24.71% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Bioatla  vs.  Syndax Pharmaceuticals

Bioatla

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bioatla has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Syndax Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Syndax Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Bioatla and Syndax Pharmaceuticals

The main advantage of trading using opposite Bioatla and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bioatla position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.

The idea behind Bioatla and Syndax Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..